3 results
Approved WMOCompleted
To characterize safety, tolerability, pharmacodynamic effects, and pharmacokinetics of the oral sGC stimulator BAY 1021189 in addition to standard therapy for heart failure with reduced EF (HFrEF) over 12 weeks in patients with worsening chronic…
Approved WMOPending
To achieve earlier sport resumption in more patients due to PEMFs compared to placebo.
Approved WMOCompleted
The primary objective is to determine the effectiveness of RSWT versus FSWT in treating patellar tendinopathy.